Key result
MicroRNA-21 promotes dysregulated lipid metabolism and hepatocellular carcinoma development.
Design
Editorial
Interviews highlight findings on lipid metabolism and cancer biomarkers from MSTP and PhD students, indicating breakthroughs in cancer diagnosis.
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Chad VanSant-Webb and Jessye Castro are co-first authors on ‘ MicroRNA-21 promotes dysregulated lipid metabolism and hepatocellular carcinoma’, published in DMM. Chad is a Medical Scientist Training Program (MSTP) student in the lab of Dr Kimberley Evason at University of Utah, Salt Lake City, UT, USA, investigating inflammation. Jessye is a PhD student in the same lab, investigating cancer biomarkers that allow for early-stage diagnosis of cancer.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question. MicroRNA-21 promotes dysregulated lipid metabolism and hepatocellular carcinoma development.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: